Brief introduction of Chifeng pharmaceutical co., ltd

Chifeng Pharmaceutical Co., Ltd. (Chifeng Pharmaceutical Factory), founded in June 1949, is the first pharmaceutical enterprise established in Inner Mongolia Autonomous Region and the largest ephedrine production enterprise in China. After 60 years' development and change, Chifeng Pharmaceutical has developed from a small manual workshop to a large-scale comprehensive pharmaceutical enterprise based on biological fermentation technology, with pharmaceutical raw materials and nutritional raw materials as the core, integrating scientific research and development, antibiotics, nutritional drugs and energy production. In the course of 60 years' development, Chifeng Pharmaceutical has undergone several reforms and reorganizations: 200 1, Chifeng Pharmaceutical Factory and Chifeng North United Pharmaceutical Factory were reorganized into Chifeng Pharmaceutical (Group) Co., Ltd. with China Huarong Company through "debt-to-equity swap". In the same year, it invested RMB 65,438+0,654,380+0,000 to establish Chifeng Keyuan Investment Development Co., Ltd. and jointly established Chifeng Aike Pharmaceutical Technology Co., Ltd. with Haishen investors. In June of the same year +065438+ 10, the pharmaceutical factory was reorganized and Chifeng Meng Xin Pharmaceutical Co., Ltd. was established. In 2003, Chifeng Pharmaceutical and Shanghai Industry joined hands, and Shanghai invested more than 70 million yuan to produce Ike and Meng Xin. In 2008, Chifeng Pharmaceutical Co., Ltd. was established in cooperation with Shanghai Disuo Pharmaceutical Development Co., Ltd. In 2008, the company achieved sales income of 332 million yuan, profit and tax190,000 yuan, and foreign exchange earned by export of 24 million US dollars.